Copyright Reports & Markets. All rights reserved.

Global Human Interleukin-2 for Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Interleukin-2 for Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 50000 IU
    • 1.3.3 100000 IU
    • 1.3.4 200000 IU
    • 1.3.5 500000 IU
    • 1.3.6 1 Million IU
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Interleukin-2 for Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
  • 1.5 Global Human Interleukin-2 for Injection Market Size & Forecast
    • 1.5.1 Global Human Interleukin-2 for Injection Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Human Interleukin-2 for Injection Sales Quantity (2020-2031)
    • 1.5.3 Global Human Interleukin-2 for Injection Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Clinigen
    • 2.1.1 Clinigen Details
    • 2.1.2 Clinigen Major Business
    • 2.1.3 Clinigen Human Interleukin-2 for Injection Product and Services
    • 2.1.4 Clinigen Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Clinigen Recent Developments/Updates
  • 2.2 3SBio
    • 2.2.1 3SBio Details
    • 2.2.2 3SBio Major Business
    • 2.2.3 3SBio Human Interleukin-2 for Injection Product and Services
    • 2.2.4 3SBio Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 3SBio Recent Developments/Updates
  • 2.3 Beijing Four Rings Biopharmaceutical
    • 2.3.1 Beijing Four Rings Biopharmaceutical Details
    • 2.3.2 Beijing Four Rings Biopharmaceutical Major Business
    • 2.3.3 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Product and Services
    • 2.3.4 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Beijing Four Rings Biopharmaceutical Recent Developments/Updates
  • 2.4 Jiangsu Kingsley Pharmaceutical
    • 2.4.1 Jiangsu Kingsley Pharmaceutical Details
    • 2.4.2 Jiangsu Kingsley Pharmaceutical Major Business
    • 2.4.3 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Product and Services
    • 2.4.4 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
  • 2.5 Beijing Yuance Pharmaceutical
    • 2.5.1 Beijing Yuance Pharmaceutical Details
    • 2.5.2 Beijing Yuance Pharmaceutical Major Business
    • 2.5.3 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Product and Services
    • 2.5.4 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Beijing Yuance Pharmaceutical Recent Developments/Updates
  • 2.6 Beijing SL Pharm
    • 2.6.1 Beijing SL Pharm Details
    • 2.6.2 Beijing SL Pharm Major Business
    • 2.6.3 Beijing SL Pharm Human Interleukin-2 for Injection Product and Services
    • 2.6.4 Beijing SL Pharm Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Beijing SL Pharm Recent Developments/Updates
  • 2.7 Shanghai Huaxin Biotechnology
    • 2.7.1 Shanghai Huaxin Biotechnology Details
    • 2.7.2 Shanghai Huaxin Biotechnology Major Business
    • 2.7.3 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Product and Services
    • 2.7.4 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Shanghai Huaxin Biotechnology Recent Developments/Updates
  • 2.8 Changchun Institute Of Biological Products
    • 2.8.1 Changchun Institute Of Biological Products Details
    • 2.8.2 Changchun Institute Of Biological Products Major Business
    • 2.8.3 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Product and Services
    • 2.8.4 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Changchun Institute Of Biological Products Recent Developments/Updates
  • 2.9 Shandong Quangang Pharmaceutical
    • 2.9.1 Shandong Quangang Pharmaceutical Details
    • 2.9.2 Shandong Quangang Pharmaceutical Major Business
    • 2.9.3 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Product and Services
    • 2.9.4 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Shandong Quangang Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Human Interleukin-2 for Injection by Manufacturer

  • 3.1 Global Human Interleukin-2 for Injection Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Human Interleukin-2 for Injection Revenue by Manufacturer (2020-2025)
  • 3.3 Global Human Interleukin-2 for Injection Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Human Interleukin-2 for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Human Interleukin-2 for Injection Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Human Interleukin-2 for Injection Manufacturer Market Share in 2024
  • 3.5 Human Interleukin-2 for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Human Interleukin-2 for Injection Market: Region Footprint
    • 3.5.2 Human Interleukin-2 for Injection Market: Company Product Type Footprint
    • 3.5.3 Human Interleukin-2 for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Interleukin-2 for Injection Market Size by Region
    • 4.1.1 Global Human Interleukin-2 for Injection Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Human Interleukin-2 for Injection Consumption Value by Region (2020-2031)
    • 4.1.3 Global Human Interleukin-2 for Injection Average Price by Region (2020-2031)
  • 4.2 North America Human Interleukin-2 for Injection Consumption Value (2020-2031)
  • 4.3 Europe Human Interleukin-2 for Injection Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Human Interleukin-2 for Injection Consumption Value (2020-2031)
  • 4.5 South America Human Interleukin-2 for Injection Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Human Interleukin-2 for Injection Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Human Interleukin-2 for Injection Sales Quantity by Type (2020-2031)
  • 5.2 Global Human Interleukin-2 for Injection Consumption Value by Type (2020-2031)
  • 5.3 Global Human Interleukin-2 for Injection Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Human Interleukin-2 for Injection Sales Quantity by Application (2020-2031)
  • 6.2 Global Human Interleukin-2 for Injection Consumption Value by Application (2020-2031)
  • 6.3 Global Human Interleukin-2 for Injection Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Human Interleukin-2 for Injection Sales Quantity by Type (2020-2031)
  • 7.2 North America Human Interleukin-2 for Injection Sales Quantity by Application (2020-2031)
  • 7.3 North America Human Interleukin-2 for Injection Market Size by Country
    • 7.3.1 North America Human Interleukin-2 for Injection Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Human Interleukin-2 for Injection Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Human Interleukin-2 for Injection Sales Quantity by Type (2020-2031)
  • 8.2 Europe Human Interleukin-2 for Injection Sales Quantity by Application (2020-2031)
  • 8.3 Europe Human Interleukin-2 for Injection Market Size by Country
    • 8.3.1 Europe Human Interleukin-2 for Injection Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Human Interleukin-2 for Injection Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Interleukin-2 for Injection Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Human Interleukin-2 for Injection Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Human Interleukin-2 for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Human Interleukin-2 for Injection Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Human Interleukin-2 for Injection Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Human Interleukin-2 for Injection Sales Quantity by Type (2020-2031)
  • 10.2 South America Human Interleukin-2 for Injection Sales Quantity by Application (2020-2031)
  • 10.3 South America Human Interleukin-2 for Injection Market Size by Country
    • 10.3.1 South America Human Interleukin-2 for Injection Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Human Interleukin-2 for Injection Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Interleukin-2 for Injection Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Human Interleukin-2 for Injection Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Human Interleukin-2 for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Human Interleukin-2 for Injection Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Human Interleukin-2 for Injection Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Human Interleukin-2 for Injection Market Drivers
  • 12.2 Human Interleukin-2 for Injection Market Restraints
  • 12.3 Human Interleukin-2 for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Interleukin-2 for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Interleukin-2 for Injection
  • 13.3 Human Interleukin-2 for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Interleukin-2 for Injection Typical Distributors
  • 14.3 Human Interleukin-2 for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Interleukin-2 for Injection market size was valued at US$ 48.2 million in 2024 and is forecast to a readjusted size of USD 64.9 million by 2031 with a CAGR of 4.4% during review period.
    Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body"s immune system.
    Human Interleukin-2 (IL-2) is a vital immunoregulatory protein used in the treatment of various cancers and immune-related diseases. The market is substantial and continuously expanding, benefiting from the growing population of cancer patients and the widespread application of immunotherapy. Sales are consistently rising, especially in novel immunotherapy fields like CAR-T cell therapy. Specific uses include the treatment of malignancies such as malignant melanoma, renal cell carcinoma, and advanced metastatic colorectal cancer. The future development prospects are promising, with anticipated approvals for more indications and treatment modalities driving continued market growth.
    This report is a detailed and comprehensive analysis for global Human Interleukin-2 for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Interleukin-2 for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Human Interleukin-2 for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Human Interleukin-2 for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Human Interleukin-2 for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Interleukin-2 for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Interleukin-2 for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biotechnology, Changchun Institute Of Biological Products, Shandong Quangang Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Interleukin-2 for Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50000 IU
    100000 IU
    200000 IU
    500000 IU
    1 Million IU
    Market segment by Application
    Hospital
    Pharmacy
    Major players covered
    Clinigen
    3SBio
    Beijing Four Rings Biopharmaceutical
    Jiangsu Kingsley Pharmaceutical
    Beijing Yuance Pharmaceutical
    Beijing SL Pharm
    Shanghai Huaxin Biotechnology
    Changchun Institute Of Biological Products
    Shandong Quangang Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Interleukin-2 for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Interleukin-2 for Injection, with price, sales quantity, revenue, and global market share of Human Interleukin-2 for Injection from 2020 to 2025.
    Chapter 3, the Human Interleukin-2 for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Interleukin-2 for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Interleukin-2 for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Interleukin-2 for Injection.
    Chapter 14 and 15, to describe Human Interleukin-2 for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now